In the second article in a series on the leadership benefits of putting employees first, Christine Miller, president and CEO ...

Part one of a two-part series that identifies current uses of AI in drug discovery and development and assesses whether AI ...

An LLC model in biotech brings specific advantages, such as streamlined deal-making, IP ownership, and capital reinvestment ...

What do Annovis Bio’s buntanetap, Pfizer’s Viagra, and Lilly’s GLP-1 drug Trulicity have in common? They could all end up being used together in combination as a new treatment focused on improving ...

Then: In a 2021 “Companies To Watch” article written by Wayne Koberstein, Carisma Therapeutics CEO Steven Kelly spoke about his three-pronged mandate to fund the (then) privately held company, build a ...

We live in a time of hope for millions around the world, as technological advancements and research breakthroughs hold the promise of transformative treatments and cures. And with social media at our ...

Over the past decade, advances in drug discovery and clinical development have led to a rise in the number of approved therapies, resulting in an increasingly competitive marketplace. These evolving ...

Michael Bailey’s career journey is unique among biotech executives.